\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ showed\\ an\\ irritated\\ cervical\\ os\\,\\ and\\ pap\\ smear\\ results\\ returned\\ high\\-grade\\ sil\\.\\ \\ \ \(0\)\
\-\ patient\\ was\\ then\\ referred\\ to\\ ob\\/gyn\\.\ \(0\)\
\-\ patient\\ returned\\ to\\ ir\\ 4\\ weks\\ later\\ for\\ removal\\ of\\ nus\\ and\\ placement\\ of\\ antegrade\\ ureteral\\ stent\\.\\ from\\ this\\ point\\ on\\,\\ the\\ stent\\ can\\ be\\ exchanged\\ through\\ the\\ bladder\\ by\\ urology\\ service\\.\ \(0\)\
\-\ normal\\ pelvic\\ ultrasound\\.\ \(1\)\
\-\ pet\\/ct\\ \\-\\ right\\ hydronephrosis\\ with\\ abnormal\\ pelvic\\ uptake\\ in\\ region\\ of\\ uterus\\.\\ no\\ pathologic\\ up\\-take\\ seen\\ in\\ region\\ of\\ local\\ lymph\\ nodes\\.\ \(0\)\
\-\ fluoroscopic\\ images\\ obtained\\ during\\ a\\ right\\ percutaneous\\ nephrostomy\\ tube\\ placement\\ showed\\ right\\ sided\\ hydronephrosis\\ and\\ high\\-grade\\ stricture\\ of\\ distal\\ right\\ ureter\\.\\ \\ stricture\\ was\\ dilated\\ using\\ balloon\\ angioplasty\\ technique\\,\\ and\\ a\\ nephroureteral\\ stent\\ \\(nus\\)\\ was\\ placed\\.\ \(0\)\
\-\ cervical\\ cancer\\ \\-\\ stage\\ iiib\\ with\\ ureteral\\ obstruction\ \(0\)\
\-\ transitional\\ cell\\ carcinoma\\.\ \(2\)\
\-\ endometrial\\ carcinoma\\.\ \(1\)\
\-\ drop\\ metastasis\ \(4\)\
\-\ patient\\ is\\ a\\ 42\\ y\\/o\\ g5\\ p4014\\ woman\\ who\\ had\\ not\\ had\\ cervical\\ cancer\\ screening\\ for\\ several\\ years\\.\\ patient\\ developed\\ right\\ sided\\ pelvic\\ pain\\ and\\ presented\\ to\\ a\\ local\\ emergency\\ department\\,\\ where\\ she\\ was\\ initially\\ felt\\ to\\ have\\ an\\ enlarged\\ uterus\\ and\\ symptomatic\\ fibroids\\.\\ \\ \ \(0\)\
\-\ she\\ was\\ referred\\ to\\ a\\ local\\ primary\\ care\\ physician\\ for\\ a\\ pap\\ smear\\.\ \(0\)\
\-\ in\\ the\\ management\\ of\\ cervical\\ cancer\\,\\ surgical\\ candidacy\\ is\\ in\\ part\\ based\\ on\\ an\\ assessment\\ of\\ parametrial\\ tumor\\ extension\\ by\\ physical\\ examination\\.\\ \ \(0\)\
\-\ radical\\ hysterectomy\\ is\\ usually\\ reserved\\ for\\ medically\\-fit\\ patients\\ with\\ tumor\\ confined\\ to\\ the\\ cervix\\ \\(stage\\ i\\)\\ or\\ with\\ minimal\\ extension\\ to\\ the\\ proximal\\ vagina\\ \\(stage\\ iia\\)\\.\\ radiation\\ therapy\\ is\\ the\\ treatment\\ of\\ choice\\ for\\ tumor\\ that\\ has\\ spread\\ to\\ the\\ parametria\\ or\\ beyond\\ \\(stage\\ iib\\ or\\ greater\\)\\.\\ several\\ previous\\ studies\\ have\\ demonstrated\\ that\\ computed\\ tomography\\ has\\ a\\ disappointing\\ accuracy\\ \\(of\\ only\\ approximately\\ 50\\%\\)\\ in\\ evaluating\\ parametrial\\ extension\\ of\\ cervix\\ cancer\\.\\ ct\\ alone\\ usually\\ cannot\\ accurately\\ differentiate\\ stage\\ lb\\ from\\ iib\\ lesions\\ and\\ thus\\ usually\\ does\\ not\\ play\\ a\\ significant\\ role\\ in\\ deciding\\ surgical\\ vs\\.\\ nonsurgical\\ treatment\\.\\ in\\ this\\ particular\\ case\\,\\ the\\ right\\ sided\\ hydronephrosis\\ makes\\ parametrial\\ extension\\ more\\ obvious\\.\\ \\ the\\ pet\\ scan\\ findings\\ further\\ help\\ with\\ staging\\ and\\ management\\ in\\ this\\ patient\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parametrial\\:\\ 0\\.26108368330752935\ \(0\)\
\-\ stage\\:\\ 0\\.21668288078676456\ \(0\)\
\-\ nus\\:\\ 0\\.17405578887168627\ \(0\)\
\-\ stent\\:\\ 0\\.16471272085967614\ \(0\)\
\-\ cervical\\:\\ 0\\.15590354906307274\ \(0\)\
\-\ extension\\:\\ 0\\.1540889637887073\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.1515091538107168\ \(0\)\
\-\ iib\\:\\ 0\\.15015333042262405\ \(0\)\
\-\ cancer\\:\\ 0\\.1449877178433426\ \(0\)\
\-\ local\\:\\ 0\\.1405338976469258\ \(0\)\
\-\ pap\\:\\ 0\\.13986938861803308\ \(0\)\
\-\ smear\\:\\ 0\\.13438047414957813\ \(0\)\
\-\ pelvic\\:\\ 0\\.12761750257747753\ \(0\)\
\-\ cervix\\:\\ 0\\.1266442837106637\ \(0\)\
\-\ ureteral\\:\\ 0\\.11341917880329432\ \(0\)\
\-\ to\\:\\ 0\\.10883722785903717\ \(0\)\
\-\ in\\:\\ 0\\.10830153124892464\ \(0\)\
\-\ right\\:\\ 0\\.10825298336557453\ \(0\)\
\-\ of\\:\\ 0\\.10649565553552011\ \(0\)\
\-\ stricture\\:\\ 0\\.10541981462965602\ \(0\)\
\-\ sided\\:\\ 0\\.10501530330526385\ \(0\)\
\-\ usually\\:\\ 0\\.10277640867293707\ \(0\)\
\-\ returned\\:\\ 0\\.10229286823559006\ \(0\)\
\-\ pet\\:\\ 0\\.10079983249620311\ \(0\)\
\-\ the\\:\\ 0\\.09772713573666669\ \(0\)\
\-\ uterus\\:\\ 0\\.09546541112501057\ \(0\)\
\-\ was\\:\\ 0\\.09482787370169515\ \(0\)\
\-\ and\\:\\ 0\\.08996022942684544\ \(0\)\
\-\ patient\\:\\ 0\\.08849891152905094\ \(0\)\
\-\ sil\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ weks\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ nephroureteral\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ g5\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ p4014\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ parametria\\:\\ 0\\.08702789443584313\ \(0\)\
\-\ tumor\\:\\ 0\\.08539294822696397\ \(0\)\
\-\ placement\\:\\ 0\\.08498854762352977\ \(0\)\
\-\ exchanged\\:\\ 0\\.08315979921638592\ \(0\)\
\-\ candidacy\\:\\ 0\\.08315979921638592\ \(0\)\
\-\ for\\:\\ 0\\.08246996916623278\ \(0\)\
\-\ referred\\:\\ 0\\.08053495727836081\ \(0\)\
\-\ disappointing\\:\\ 0\\.08041534198215844\ \(0\)\
\-\ deciding\\:\\ 0\\.08041534198215844\ \(0\)\
\-\ management\\:\\ 0\\.08039362483015583\ \(0\)\
\-\ irritated\\:\\ 0\\.07828657556840098\ \(0\)\
\-\ iiib\\:\\ 0\\.07267915154324402\ \(0\)\
\-\ iia\\:\\ 0\\.07267915154324402\ \(0\)\
\-\ showed\\:\\ 0\\.0724938589216713\ \(0\)\
\-\ several\\:\\ 0\\.07140845957868594\ \(0\)\
\-\ nonsurgical\\:\\ 0\\.06917109515162166\ \(0\)\
\-\ antegrade\\:\\ 0\\.06846411275762733\ \(0\)\
\-\ nephrostomy\\:\\ 0\\.06846411275762733\ \(0\)\
\-\ vagina\\:\\ 0\\.06846411275762733\ \(0\)\
\-\ accurately\\:\\ 0\\.06719023707478906\ \(0\)\
\-\ ir\\:\\ 0\\.0666118844492729\ \(0\)\
\-\ play\\:\\ 0\\.06606659908955932\ \(0\)\
\-\ lb\\:\\ 0\\.06555080338743173\ \(0\)\
\-\ region\\:\\ 0\\.06510202192474303\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06510202192474303\ \(0\)\
\-\ she\\:\\ 0\\.06478871778702987\ \(0\)\
\-\ accuracy\\:\\ 0\\.06372815617760831\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.06332214185533185\ \(0\)\
\-\ reserved\\:\\ 0\\.06332214185533185\ \(0\)\
\-\ an\\:\\ 0\\.06242897641084023\ \(0\)\
\-\ angioplasty\\:\\ 0\\.0615167927402434\ \(0\)\
\-\ fibroids\\:\\ 0\\.0615167927402434\ \(0\)\
\-\ radical\\:\\ 0\\.06028412617821146\ \(0\)\
\-\ urology\\:\\ 0\\.05972279389018518\ \(0\)\
\-\ is\\:\\ 0\\.05961209696450737\ \(0\)\
\-\ drop\\:\\ 0\\.05919266325428215\ \(0\)\
\-\ physical\\:\\ 0\\.05901450709542487\ \(0\)\
\-\ transitional\\:\\ 0\\.058690447478479756\ \(0\)\
\-\ confined\\:\\ 0\\.05821335323564719\ \(0\)\
\-\ os\\:\\ 0\\.057758986571479716\ \(0\)\
\-\ differentiate\\:\\ 0\\.05732528022211717\ \(0\)\
\-\ role\\:\\ 0\\.05711560372392362\ \(0\)\
\-\ balloon\\:\\ 0\\.05691043674915724\ \(0\)\
\-\ or\\:\\ 0\\.05679424660642289\ \(0\)\
\-\ beyond\\:\\ 0\\.05670958940164716\ \(0\)\
\-\ service\\:\\ 0\\.05632015179358944\ \(0\)\
\-\ technique\\:\\ 0\\.056131236776130994\ \(0\)\
\-\ this\\:\\ 0\\.056098088009524774\ \(0\)\
\-\ endometrial\\:\\ 0\\.05558595141641743\ \(0\)\
\-\ staging\\:\\ 0\\.05558595141641743\ \(0\)\
\-\ evaluating\\:\\ 0\\.054741161159319\ \(0\)\
\-\ makes\\:\\ 0\\.054580822987889695\ \(0\)\
\-\ have\\:\\ 0\\.05437059240939799\ \(0\)\
\-\ had\\:\\ 0\\.05422713464134343\ \(0\)\
\-\ fluoroscopic\\:\\ 0\\.053817223830494816\ \(0\)\
\-\ alone\\:\\ 0\\.05352811392889611\ \(0\)\
\-\ ureter\\:\\ 0\\.053386779541903524\ \(0\)\
\-\ with\\:\\ 0\\.053279643332163035\ \(0\)\
\-\ assessment\\:\\ 0\\.053247508504466405\ \(0\)\
\-\ particular\\:\\ 0\\.05311024143650049\ \(0\)\
\-\ surgical\\:\\ 0\\.05289885864897244\ \(0\)\
\-\ tomography\\:\\ 0\\.05270990731482801\ \(0\)\
\-\ percutaneous\\:\\ 0\\.05245205657413223\ \(0\)\
\-\ computed\\:\\ 0\\.05245205657413223\ \(0\)\
\-\ treatment\\:\\ 0\\.051845354076734754\ \(0\)\
\-\ choice\\:\\ 0\\.0516008007819625\ \(0\)\
\-\ obvious\\:\\ 0\\.050607313473405864\ \(0\)\
\-\ thus\\:\\ 0\\.04999817703081824\ \(0\)\
\-\ help\\:\\ 0\\.04999817703081824\ \(0\)\
\-\ has\\:\\ 0\\.04971406504866165\ \(0\)\
\-\ spread\\:\\ 0\\.0488854730257339\ \(0\)\
\-\ part\\:\\ 0\\.048626455396573266\ \(0\)\
\-\ 42\\:\\ 0\\.048374284856481466\ \(0\)\
\-\ felt\\:\\ 0\\.04781058270218227\ \(0\)\
\-\ physician\\:\\ 0\\.047732705562505286\ \(0\)\
\-\ that\\:\\ 0\\.04723164643395319\ \(0\)\
\-\ nodes\\:\\ 0\\.046228941728505266\ \(0\)\
\-\ by\\:\\ 0\\.046218962376482264\ \(0\)\
\-\ department\\:\\ 0\\.04603223585995432\ \(0\)\
\-\ point\\:\\ 0\\.04498824832827781\ \(0\)\
\-\ using\\:\\ 0\\.04475836017711605\ \(0\)\
\-\ pathologic\\:\\ 0\\.04458950804114793\ \(0\)\
\-\ screening\\:\\ 0\\.0442067674474983\ \(0\)\
\-\ tube\\:\\ 0\\.04348448449427778\ \(0\)\
\-\ from\\:\\ 0\\.043225872320865805\ \(0\)\
\-\ not\\:\\ 0\\.042966686190553216\ \(0\)\
\-\ where\\:\\ 0\\.04276686083132451\ \(0\)\
\-\ initially\\:\\ 0\\.04267513034925728\ \(0\)\
\-\ results\\:\\ 0\\.04240511525035287\ \(0\)\
\-\ placed\\:\\ 0\\.04240511525035287\ \(0\)\
\-\ lymph\\:\\ 0\\.04231678224302766\ \(0\)\
\-\ bladder\\:\\ 0\\.04222925964168611\ \(0\)\
\-\ uptake\\:\\ 0\\.04184505080692046\ \(0\)\
\-\ symptomatic\\:\\ 0\\.04184505080692046\ \(0\)\
\-\ removal\\:\\ 0\\.04159724735165317\ \(0\)\
\-\ minimal\\:\\ 0\\.041516056251949617\ \(0\)\
\-\ vs\\:\\ 0\\.041516056251949617\ \(0\)\
\-\ ct\\:\\ 0\\.04143568006581107\ \(0\)\
\-\ previous\\:\\ 0\\.04112015310882059\ \(0\)\
\-\ developed\\:\\ 0\\.040374469255531245\ \(0\)\
\-\ emergency\\:\\ 0\\.040374469255531245\ \(0\)\
\-\ greater\\:\\ 0\\.04009178496932986\ \(0\)\
\-\ studies\\:\\ 0\\.03991926857495965\ \(0\)\
\-\ metastasis\\:\\ 0\\.03988513652913111\ \(0\)\
\-\ based\\:\\ 0\\.039419683406269626\ \(0\)\
\-\ dilated\\:\\ 0\\.038975887265768186\ \(0\)\
\-\ later\\:\\ 0\\.03894496374879656\ \(0\)\
\-\ care\\:\\ 0\\.038883415815100256\ \(0\)\
\-\ then\\:\\ 0\\.03852224094717682\ \(0\)\
\-\ obtained\\:\\ 0\\.03849275128959083\ \(0\)\
\-\ obstruction\\:\\ 0\\.03811745734110313\ \(0\)\
\-\ 50\\:\\ 0\\.038004890883069\ \(0\)\
\-\ does\\:\\ 0\\.037621050163779944\ \(0\)\
\-\ enlarged\\:\\ 0\\.037098185253005386\ \(0\)\
\-\ radiation\\:\\ 0\\.036062577895572594\ \(0\)\
\-\ further\\:\\ 0\\.03544403466167648\ \(0\)\
\-\ examination\\:\\ 0\\.03482299786368772\ \(0\)\
\-\ approximately\\:\\ 0\\.03472331151637599\ \(0\)\
\-\ during\\:\\ 0\\.03446889919584089\ \(0\)\
\-\ proximal\\:\\ 0\\.033997930087493244\ \(0\)\
\-\ only\\:\\ 0\\.033997930087493244\ \(0\)\
\-\ ultrasound\\:\\ 0\\.033566674893496844\ \(0\)\
\-\ primary\\:\\ 0\\.03346183980958315\ \(0\)\
\-\ demonstrated\\:\\ 0\\.03344447875541499\ \(0\)\
\-\ years\\:\\ 0\\.0333581442600134\ \(0\)\
\-\ on\\:\\ 0\\.03287096924838658\ \(0\)\
\-\ abnormal\\:\\ 0\\.03269423144993026\ \(0\)\
\-\ through\\:\\ 0\\.032394358893514934\ \(0\)\
\-\ scan\\:\\ 0\\.0322862131581826\ \(0\)\
\-\ presented\\:\\ 0\\.03173410261725675\ \(0\)\
\-\ distal\\:\\ 0\\.03161881545431366\ \(0\)\
\-\ significant\\:\\ 0\\.031420355767091984\ \(0\)\
\-\ therapy\\:\\ 0\\.0312672688016318\ \(0\)\
\-\ lesions\\:\\ 0\\.03125347285326577\ \(0\)\
\-\ cell\\:\\ 0\\.031130198963255456\ \(0\)\
\-\ who\\:\\ 0\\.03078276937439254\ \(0\)\
\-\ patients\\:\\ 0\\.030613687025785926\ \(0\)\
\-\ more\\:\\ 0\\.029881874308902316\ \(0\)\
\-\ can\\:\\ 0\\.028557388976162505\ \(0\)\
\-\ woman\\:\\ 0\\.028341614749009317\ \(0\)\
\-\ exam\\:\\ 0\\.027394572715612034\ \(0\)\
\-\ case\\:\\ 0\\.02733953469776669\ \(0\)\
\-\ findings\\:\\ 0\\.026857979745231096\ \(0\)\
\-\ seen\\:\\ 0\\.02562004412303784\ \(0\)\
\-\ images\\:\\ 0\\.025172429732882643\ \(0\)\
\-\ normal\\:\\ 0\\.022218929754307098\ \(0\)\
\-\ be\\:\\ 0\\.02207562958615194\ \(0\)\
\-\ pain\\:\\ 0\\.019473135744818897\ \(0\)\
\-\ no\\:\\ 0\\.017696453079940576\ \(0\)\
